Skip to main content
TipRanks
Go Ultimate75% OFF

Collegium Pharmaceutical (COLL) Q3 2020 Earnings Report

511 Followers

COLL Q3 2020 EPS Results

Actual EPS
$1.03
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
$0.05

COLL Q3 2020 Revenue Results

Actual Revenue
$79.18M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+8.55%

Earnings Announcement Details

Quarter
Q3 2020
Date
11/05/2020
Time
After Close
Conference Call
Thursday, November 5, 2020
COLL Upcoming Earnings

Collegium Pharmaceutical's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q3 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

COLL Earnings History

COLL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 25, 20272026 (Q4)1.92-2.04――
Nov 05, 20262026 (Q3)1.861.962.25-12.89% (-0.29)
Aug 06, 20262026 (Q2)1.721.921.6814.29% (+0.24)
May 07, 20262026 (Q1)1.521.761.4918.12% (+0.27)
Feb 26, 20262025 (Q4)2.142.041.7715.25% (+0.27)
Nov 06, 20252025 (Q3)1.862.251.6139.75% (+0.64)
Aug 07, 20252025 (Q2)1.621.681.623.70% (+0.06)
May 08, 20252025 (Q1)1.431.491.452.76% (+0.04)
Feb 27, 20252024 (Q4)1.541.771.5812.03% (+0.19)
Nov 07, 20242024 (Q3)1.591.611.3420.15% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed